Moreover, in rats with liver fibrosis, it can reduce VEGFA, angiotensin I, and transforming growth factor beta 1, as well as the expression of its signal transmission medium, exert antiangiogenic effects by alleviating oxidative stress. Here, VEGFA is linked to Hepatic fibrosis.